sj-docx-1-cra-10.1177_11795484211006050 – Supplemental material for Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib

Rahaghi, Franck; Belperio, John A; Fitzgerald, John; Gulati, Mridu; Hallowell, Robert; Highland, Kristin B; Huie, Tristan J; Kim, Hyun J; Kolb, Martin; Lasky, Joseph A; Southern, Brian D; Swigris, Jeffrey J; de Andrade, Joao A

doi:10.25384/SAGE.14343571.v1

sj-docx-1-cra-10.1177_11795484211006050.docx (2.13 MB)

sj-docx-1-cra-10.1177_11795484211006050 – Supplemental material for Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib

journal contribution

posted on 2021-03-31, 00:06 authored by Franck Rahaghi, John A Belperio, John Fitzgerald, Mridu Gulati, Robert Hallowell, Kristin B Highland, Tristan J Huie, Hyun J Kim, Martin Kolb, Joseph A Lasky, Brian D Southern, Jeffrey J Swigris, Joao A de Andrade

Supplemental material, sj-docx-1-cra-10.1177_11795484211006050 for Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib by Franck Rahaghi, John A Belperio, John Fitzgerald, Mridu Gulati, Robert Hallowell, Kristin B Highland, Tristan J Huie, Hyun J Kim, Martin Kolb, Joseph A Lasky, Brian D Southern, Jeffrey J Swigris and Joao A de Andrade in Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine